Dear User Advisorymandi.com or Pro advisory Championship (PAC) having purpose to provide you analytical skills of numbers of SEBI registered Research Analysts and Investment Advisers to choose best one among them for your hard earned investments. We Advisorymandi.com or Pro advisory Championship (PAC) not promote any adviser or provide any advise through Call, SMS and Social media platforms or give assurance of any return.

Change Mobile Number

Update Profile

Trump says pharma 'getting away with murder,' stocks slide

NEW YORK (Reuters) - U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder" in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower.

The benchmark S&P 500 index slipped into negative territory after his remarks at a news conference spooked investors. The Ishares Nasdaq Biotech ETF <IBB.O> dropped 4 percent at its session low and was on track for its largest daily percentage drop since late June. [nL4N1F14CH]

"When the president-elect says we're going to negotiate drug pricing, you have to take that seriously, but at the same this is a complicated issue because there's not going to be clarity on drug pricing reform anytime soon," said Brad Loncar, manager of the Loncar Cancer Immunotherapy ETF <CNCR.O>. "When somebody that high profile says something that negative, people do not want to invest in it."

Trump has blasted other industries for charging the government too much, particularly defence companies, but has made only a few public statements about drug pricing since being elected. He briefly mentioned Lockheed Martin Corp <LMT.N> and Ford & Co <F.N>, and United Technologies Corp <UTX.N> during the Wednesday news conference and promised a border tax for companies producing products for U.S. consumers outside the United States.

The drug industry has been on edge for two years about the potential for more government pressure on pricing after sharp increases in the costs of some life-saving drugs drew scrutiny in the press and among lawmakers. The government is investigating Medicaid and Medicare overspending on Mylan NV's <MYL.O> allergy treatment EpiPen, for instance.

David Katz, chief investment officer at Matrix Asset Advisors in New York, said negative comments on drug pricing trigger selling both from algorithms and investors who suffered from share drops when Democrat Hillary Clinton campaigned against healthcare cost increases.

Trading volume in the healthcare fund's options jumped to 52,000 contracts, more than twice the average daily volume, with bearish/defensive bets dominating, according to options analytics firm Trade Alert data.

Trump's campaign platform included allowing the Medicare healthcare program to negotiate with pharmaceutical companies, which the law currently prohibits. He has also discussed making it easier to import drugs at cheaper prices.

"We are going to start bidding. We are going to save billions of dollars over time," Trump said.

Medicare, which covers more than 55 million elderly or disabled Americans, spent $325 billion on medicines in 2015.

Industry trade group Pharmaceutical Research and Manufacturers of America, or PhRMA President Stephen Ubl said "Medicines are purchased in a competitive marketplace where large, sophisticated purchasers aggressively negotiate lower prices."

He said the industry is "committed to working with President-elect Trump and Congress to improve American competitiveness and protect American jobs."

Daniel O’Day, CEO of Roche Pharmaceuticals, a division of Roche Holding AG<ROG.S>, said in an interview on the sidelines of the JP Morgan conference that the company focuses on innovation and investing in research.

Price increases over the past several years have been "responsible" and in the range of low to mid single digits, he said.

Mylan CEO Heather Bresch said it was premature to respond to Trump's comments, when she was asked during an investor presentation at the JP Morgan Healthcare conference in San Francisco. She said the industry should relook at how healthcare is set up as the government repeals the Affordable Care Act.

Trump said he plans to repeal the Affordable Care Act, or Obamacare, and replace it at about the same time. The news helped shares of hospitals, which are nervous about losing government payments for medical services. It hurt some health insurers, like Anthem Inc. <ANTM.N>, which sell plans on the government-run health insurance exchanges.

The healthcare sector <.SPXHC> was the largest drag on the S&P 500 <.SPX> and the Nasdaq 100 <.NDX> while all major U.S. stock indexes were lower in mid-afternoon trading on Wall Street.

(Reporting by Caroline Humer, Rodrigo Campos and Lewis Krauskopf in New York, Deena Beasley in San Francisco and Ankur Banerjee and Natalie Grover in Bengaluru; Editing by Chizu Nomiyama and David Gregorio)

LIVE ADVISORY

TESTIMONIALS

Samiul Shanti

Pro advisory gives excellent stocks and future tips.It is a very good platform for new traders like ... Read More

Samiul Shanti

Pro advisory gives excellent stocks and future tips.It is a very good platform for new traders like me and provides exact entry and exit point.As I am a working professional I can't monitor the market for whole day, so I don't trade regularly.But I made profit in nifty future segment without monitoring the market.Thanks for this unique concept and good effort.
Regards
Samiul Shanti.

Sandeep Paliwal

Dear sir/madam,
This is Sandeep Paliwal from Delhi. I want to thank the team of ADVISORY MANDI that ... Read More

Sandeep Paliwal

Dear sir/madam,
This is Sandeep Paliwal from Delhi. I want to thank the team of ADVISORY MANDI that help me to earn profit in this market. I have started with 25000 and double my money in a month and half. Intraday day tips with stop loss given was beneficial for me.
Thanks

Dev Jadeja

I am very glad to inform that i like this app it's very use full. This app give guideline what to bu... Read More

Dev Jadeja

I am very glad to inform that i like this app it's very use full. This app give guideline what to buy and sell in stock so i earn profit from it .

Chandrakant Adhav

Nandan Mohanty

"Sir,
i have been following PAC since last 1 month. It is quite beneficial for me to conduct... Read More

Nandan Mohanty

"Sir,
i have been following PAC since last 1 month. It is quite beneficial for me to conduct Intraday Treading .The valuable suggestions given by expert advisers without any charge is a pleasant experience for common men.I wish great success for PAC .
Thnak you
Nandan Mohanty
"

Experts Pick

AdvisoryMandi

JIST OF OPEC MONTHLY REPORT:NON OPEC PRODUCTION ON RISING SPREE

With 14 countries, OPEC is an intergovernmental organisation, founded in 1960 in Bagdad. OPEC stated...

AdvisoryMandi

Moumita Samanta

JIST OF OPEC MONTHLY REPORT:NON OPEC PRODUCTION ON RISING SPREE

With 14 countries, OPEC is an intergovernmental organisation, founded in 1960 in Bagdad. OPEC stated...

AdvisoryMandi

Moumita Samanta

JIST OF OPEC MONTHLY REPORT:NON OPEC PRODUCTION ON RISING SPREE

With 14 countries, OPEC is an intergovernmental organisation, founded in 1960 in Bagdad. OPEC stated...

OPINION POLL

Will end of FY 2017-18, see Nifty at 11K mark?

YES

NO

Total Votes: 1473

Enter email-id to share this news

Important Information

Please fill the required Disclosure/Disclaimer.

Disclaimer

The information and material contained in these pages and the terms, conditions, and descriptions that appear are subject to change without prior notice. Investments in equity shares, debentures, commodities, etc, are not obligations of or guaranteed by the ADVISORYMANDI , and are subject to investment risks.....More